1,992 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
PFE Pfizer, Inc. $37.21 $217.66B Uptrend
Article Searches
Hochman Cole Investment Advisors, Inc. Buys First Trust Technology AlphaDEX, VanEck Vectors ... http://www.gurufocus.com/news/708394/hochman-cole-investment-advisors-inc-buys-first-trust-technology-alphadex-vaneck-vectors-morningstar-wide-moat-first-trust-health-care-alphadex-sells-vanguard-shortterm-bond-invesco-aerospace--defense-first-trust-energy-income--growth-fund Jul 16, 2018 - Hochman Cole Investment Advisors, Inc. Buys First Trust Technology AlphaDEX, VanEck Vectors Morningstar Wide Moat, First Trust Health Care AlphaDEX, Sells Vanguard Short-Term Bond, Invesco Aerospace & Defense, First Trust Energy Income & Growth Fund, Stocks: CELG,PFE,FXL,MOAT,FXH,IYE,JPM,LMBS,BSV,PPA,PWC,, release date:Jul 16, 2018
Increasing drug prices despite public scrutiny 'makes absolutely no sense,' says analyst https://www.cnbc.com/2018/07/16/increasing-drug-prices-makes-absolutely-no-sense-says-analyst.html Jul 16, 2018 - Some drug companies continue to raise prices, despite mounting public scrutiny and pressure from the president, a move one analyst says "makes no sense."
Mcrae Capital Management Inc Buys Wyndham Hotels & Resorts Inc, Procter & Gamble Co, ... http://www.gurufocus.com/news/708361/mcrae-capital-management-inc-buys-wyndham-hotels--resorts-inc-procter--gamble-co-wyndham-destinations-inc-sells-barings-global-short-duration-high-yield-fund-bristolmyers-squibb-company-jm-smucker-co Jul 16, 2018 - Mcrae Capital Management Inc Buys Wyndham Hotels & Resorts Inc, Procter & Gamble Co, Wyndham Destinations Inc, Sells Barings Global Short Duration High Yield Fund, Bristol-Myers Squibb Company, JM Smucker Co, Stocks: PG,PFE,TPR,T,AMGN,HD,WH,WYND,FDX,NVT,ICE,TXN,BMY,W, release date:Jul 16, 2018
3 Things In Biotech, July 16: Array Gets An Important Update https://seekingalpha.com/article/4187583-3-things-biotech-july-16-array-gets-important-update?source=feed_all_articles Jul 16, 2018 - Array's melanoma combo gets a guideline nod. Atossa looks for a window of opportunity in breast cancer. Astellas and Pfizer score widened approval for Xtandi.
Dividend Sensei's Portfolio Update 43: The 3 Essential Things All Investors Need To Get Rich https://seekingalpha.com/article/4187575-dividend-senseis-portfolio-update-43-3-essential-things-investors-need-get-rich?source=feed_all_articles Jul 16, 2018 - Most investors invest to get rich, which we all define differently.For most, it means at the very least, achieving a comfortable retirement, while for myself, it means becoming financially independent
Pfizer begins late-stage testing of Spark's hemophilia B gene therapy http://feeds.bizjournals.com/~r/industry_6/~3/dJflGbQwMig/pfizer-begins-late-stage-testing-of.html Jul 16, 2018 - Pfizer Inc. said Monday it has started late-stage clinical testing of an experimental gene therapy treatment, originally developed by Spark Therapeutics in Philadelphia, for patients with hemophilia B. The transfer of the gene therapy program to Pfizer from Spark is now complete, the companies said. Under the terms of a product license agreement signed in December 2014, Pfizer has now assumed sole responsibility for all subsequent pivotal studies, all regulatory activities, manufacturing and global…
Aquestive Therapeutics Readies $60 Million IPO https://seekingalpha.com/article/4187487-aquestive-therapeutics-readies-60-million-ipo?source=feed_sector_healthcare Jul 16, 2018 - Aquestive Therapeutics has filed amended terms for its $60 million U.S. IPO.The firm combines a manufacturing operation with a more recent development pipeline.AQST is pursuing an intriguing business
The Millennial Portfolio: Longer Than Long Term? https://seekingalpha.com/article/4187478-millennial-portfolio-longer-long-term?source=feed_tag_etf_portfolio_strategy Jul 16, 2018 - I have been working on my Millennial Portfolio for almost two years and have picked out 22 stocks so far.The portfolio is growth-oriented but also contains safer, low-growth stocks because I fear a be
Pfizer's Reorganizing Again. Is Its Stock a Buy Now? https://www.fool.com/investing/2018/07/16/pfizers-reorganizing-again-is-its-stock-a-buy-now.aspx?source=iedfolrf0000001 Jul 16, 2018 - The drugmaker's second reorganization in four years signals where the company is headed. But it doesn't solve its most serious problem.
Pfizer's Xtandi Gets FDA Nod for Expanded Patient Population http://www.zacks.com/stock/news/311579/pfizers-xtandi-gets-fda-nod-for-expanded-patient-population?cid=CS-ZC-FT-311579 Jul 16, 2018 - FDA approves Pfizer's (PFE) sNDA to expand the label of Xtandi to include the non-metastatic prostate cancer patient population.

Pages: 123456...200

Page 1>

Related Companies

Name Exchange Price Mkt Cap
NVS Novartis AG NYSE $76.35 $177.96B
MRK Merck & Company, Inc. NYSE $61.9 $166.53B
ABBV AbbVie Inc. NYSE $94.96 $150.69B
NVO Novo Nordisk A/S NYSE $48.84 $118.19B
ABT Abbott Laboratories NYSE $62.57 $109.7B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Pfizer
PFE - Google Finance https://www.google.com/finance?q=PFE Industry related info and international coverage Summary News
PFE - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=PFE Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options